Scientific Sessions 2025  /  Multimodality Imaging for Diagnosis, Risk Stratification and Management of Hypertrophic Cardiomyopathy  /  The good the bad and the ugly of imaging a CMI patient
Logo

American Heart Association

  41
  0

Final ID:

The good the bad and the ugly of imaging a CMI patient

  • Desai, Milind  ( Cleveland Clinic , Solon , Ohio , United States )
    • Author Disclosures:
    Milind Desai: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers Squibb:Active (exists now) ; Researcher:Cytokinetics:Active (exists now) ; Researcher:Viz AI:Active (exists now) ; Consultant:Viz AI:Active (exists now) ; Researcher:Edgewise:Active (exists now) ; Consultant:Edgewise:Active (exists now) ; Research Funding (PI or named investigator):Tenaya:Active (exists now) ; Consultant:Tenaya:Active (exists now) ; Consultant:Bristol myers Squibb:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Multimodality Imaging for Diagnosis, Risk Stratification and Management of Hypertrophic Cardiomyopathy

Friday, 11/07/2025 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
Sudden death risk assessment and multimodality imaging: Reconciling recommendations across the pond

Raman Betty

Opening Remarks

Owens Anjali

More abstracts from these authors:
Effect of selected baseline characteristics and exposure on efficacy and safety of mavacamten: A Post-Hoc Analysis from the ODYSSEY trial

Desai Milind

Opening Remarks

Desai Milind

You have to be authorized to contact abstract author. Please, Login
Not Available